Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Medexus Pharmaceuticals Inc (MDP.VN)

Medexus Pharmaceuticals Inc (MDP.VN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 146,241
  • Shares Outstanding, K 19,167
  • Annual Sales, $ 74,359 K
  • Annual Income, $ -6,236 K
  • 60-Month Beta 1.15
  • Price/Sales 1.01
  • Price/Cash Flow N/A
  • Price/Book 26.63
Trade MDP.VN with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -1.80
  • Most Recent Earnings -1.18 on N/A
  • Next Earnings Date 06/28/21
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 0.09
  • Number of Estimates 2
  • High Estimate 0.30
  • Low Estimate -0.12
  • Prior Year -0.13
  • Growth Rate Est. (year over year) +169.23%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.720 +15.33%
on 05/19/21
8.250 -6.06%
on 06/11/21
+0.630 (+8.85%)
since 05/14/21
3-Month
6.720 +15.33%
on 05/19/21
8.530 -9.14%
on 03/26/21
+0.190 (+2.51%)
since 03/16/21
52-Week
2.800 +176.79%
on 06/17/20
9.750 -20.51%
on 02/11/21
+4.900 (+171.93%)
since 06/15/20

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 8.467
2nd Resistance Point 8.303
1st Resistance Point 8.027
Last Price 7.750
1st Support Level 7.587
2nd Support Level 7.423
3rd Support Level 7.147

See More

52-Week High 9.750
Last Price 7.750
Fibonacci 61.8% 7.095
Fibonacci 50% 6.275
Fibonacci 38.2% 5.455
52-Week Low 2.800

See More

Business Summary

Medexus Pharmaceuticals Inc is a specialty pharmaceutical company. It is focused on auto-immune and pediatric diseases in the USA and Canada. The company's only reportable segment being the products sold and the marketing services offered to the pharmaceutical industry. Geographically, it derives a majority...

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar